RNA5SP534

Across TCGA pan-cancer cohorts, RNA5SP534 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNA5SP534 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP534 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP534 expression acts as an unfavorable survival marker.

STAD, COAD, and BLCA are the cancer types where RNA5SP534 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	II,III,IV	0.420	0.664	<.001	144	view →
COAD	OS	Tertile	All	0.145	0.871	<.001	108	view →
BLCA	DFS	Tertile	III,IV	0.176	0.578	<.001	72	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
LUSC	OS	Tertile	All	0.308	0.732	.004	33	view →
SKCM	OS	Tertile	III,IV	0.186	0.702	<.001	30	view →
THYM	DFS	Tertile	All	0.373	0.791	.014	9	view →
KICH	DFS	Quartile	II,III,IV	0.223	1.000	.020	7	view →
LGG	OS	Tertile	All	0.185	0.450	.044	6	view →
KIRP	OS	Tertile	All	0.793	0.934	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNA5SP534–STAD (DFS)

Open the STAD breakdown →